Interaction between viral infection, unique microbes, and interferon signaling may play a role in the development of asthma among infants.

Monday, June 21, 2021 NIAID-Funded Study of Infants with Severe Lung Infection Identifies Those at Highest Risk for Asthma Scanning electron micrograph of human RSV virions (colorized blue) and labeled with anti-RSV antibodies (colorized yellow) shedding from the surface of human lung epithelial cells. Credit: NIAID Nearly a third of infants who are hospitalized with a severe form of a common childhood lung infection called bronchiolitis develop asthma a few years later. But clinicians have been unable to predict which infants with severe bronchiolitis are at high risk for developing asthma and to understand why. Now, a NIAID-funded study published in the journal Nature Communications has taken a step toward accomplishing this. The study identifies which infants hospitalized with bronchiolitis caused by respiratory syncytial virus (RSV) are at highest risk for developing asthma by age 5 years. In conjunction with earlier research, the findings suggest that the interaction between viral infection, unique microbes, and interferon signaling may play a role in the development of asthma among infants. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107